Cargando…

493. Incidence and Characterization of Chronic Active COVID Among Patients Infected with the Novel Coronavirus (COVID-19) Receiving B-cell Depleting Therapies (BCDTs)

BACKGROUND: There have been reports of COVID-19 infection characterized by prolonged viral replication [chronic active COVID-19 (CAC)] among immunocompromised patients, including those receiving B-cell depleting therapies (BCDTs). We aimed to characterize the severity and incidence of CAC among pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kartes, Jacob, Spivak, Emily S, Imlay, Hannah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644725/ http://dx.doi.org/10.1093/ofid/ofab466.692

Ejemplares similares

501. Risk Factors for Persistent Active COVID-19 Among Patients Receiving B-Cell Depleting Therapy versus Non-B-Cell Immunosuppression
por: Voll, Kevin, et al.
Publicado: (2023)

493. Clinical and Epidemiological Features of Healthcare Workers Detected with Coronavirus Disease
por: Campbell, Melissa, et al.
Publicado: (2020)

140. Follow-up Blood Cultures for Gram-Negative Bacteremia among Adults with Cancer
por: Haak, David, et al.
Publicado: (2023)

1191. The Implementation of Nasal MRSA PCR for Pneumonia and Association with Antibiotic Use and Clinical Outcomes
por: Fenlon, Luke A, et al.
Publicado: (2023)

Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents
por: Goel, Shipra, et al.
Publicado: (2022)

981. Inducing Antimicrobial Resistance with Long-Term Antibiotics at Stage 2 Revision for Periprosthetic Joint Infection
por: Payne, Judd, et al.
Publicado: (2022)

Fr493 DISEASE ACTIVITY IS ASSOCIATED WITH COVID-19 OUTCOMES IN IBD PATIENTS WITH EFFECT MODIFICATION BY AGE
por: Ricciuto, Amanda, et al.
Publicado: (2021)

493. Laboratory Evaluation and Epidemiology of Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae in Department of Veterans Affairs, 2017
por: Pfeiffer, Christopher, et al.
Publicado: (2019)

553. Critically Ill patients Receiving Tocilizumab Compared With Those Not Receiving Tocilizumab for Treatment of COVID-19
por: Leonard, Michael, et al.
Publicado: (2020)

376. COVID-19 Severity in HIV+ Patients Receiving Tenofovir
por: Homsi, Nora, et al.
Publicado: (2020)

470. Relapsing COVID-19 Pneumonia in Patients Receiving Rituximab Therapy
por: Gallagher, Jolie, et al.
Publicado: (2021)

280. Burden of Hyperglycemia in Patients Receiving Dexamethasone for Severe COVID-19
por: Fetters, Kirk B, et al.
Publicado: (2021)

493. Development of a Simple Clostridium difficile Infection Clinical Risk Prediction Tool for Medical Inpatients
por: Ma, Winnie, et al.
Publicado: (2018)

53. Incidence of Bloodstream Infections and Outcomes in Patients with Severe COVID-19 Pneumonia
por: Papamanoli, Aikaterini, et al.
Publicado: (2020)

493. ENDURANCE - EffectiveNess of Evusheld for COVID-19 Pre-exposUre PRophylAxis iN ImmunoCompromised PatiEnts – A Pilot Study
por: Polega, James, et al.
Publicado: (2023)

499. Infection with Coronavirus Disease 19 (COVID-19) in Healthcare Personnel with Exposure to COVID-19
por: Kang, Minji, et al.
Publicado: (2020)

PM493. Interactions of tardive dyskinesia with cognitive function in patients with schizophrenia: worsening of working memory with clozapine treatment
por: Kim, Soo In, et al.
Publicado: (2016)

400. Secondary Infections in COVID-19 Patients Receiving Tocilizumab in a Community Hospital
por: Usiak, Shauna, et al.
Publicado: (2020)

610. Incidence of Acute Kidney Injury in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Vancomycin
por: Hamad, Yasir, et al.
Publicado: (2020)

692. Secondary Infections and Coinfections in Coronavirus Disease 2019 (COVID-19)
por: Kaur, Ikwinder P, et al.
Publicado: (2020)

1569. Incidence, Risk Factors, and Impact of Antiviral Prophylaxis Duration on Cytomegalovirus (CMV) Disease in High-Risk Donor Seropositive/Recipient Seronegative [D+R−] Orthotopic Heart Transplant Recipients (OHTR)
por: Carcoana, Allison Dumitriu, et al.
Publicado: (2018)

80. The Utility of Cultures for Isolated Fevers in Patients with Influenza or COVID-19 Receiving Extracorporeal Membrane Oxygenation
por: Marcus, Joseph E, et al.
Publicado: (2021)

341. Evaluation of Antimicrobial Use and Prescribing Patterns During the COVID-19 Pandemic in Patients Receiving Tocilizumab
por: Barsoum, Barbara, et al.
Publicado: (2021)

382. Incidence of Hospital-Acquired and Ventilator-Associated Pneumonia in Patients with Severe COVID 19 on High Flow Oxygen
por: Papamanoli, Aikaterini, et al.
Publicado: (2020)

374. Complication with Bacterial Pneumonia in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19)
por: Kang, Minji, et al.
Publicado: (2020)

444. Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers in Southeast Michigan
por: Vahia, Amit T, et al.
Publicado: (2020)

289. Post COVID Syndrome Cohort Characterization
por: Chatwani, Bhoomija, et al.
Publicado: (2021)

527. A Descriptive, Retrospective Analysis of COVID-19 Antibody Therapy and its Effects on Morbidity and Mortality in Patients Receiving B-cell Depleting Therapies
por: SIMEUNOVIC, G O R D A N A, et al.
Publicado: (2023)

11. People Living with HIV During the COVID-19 Pandemic: Who Did (or Did Not) Receive Annual Influenza Vaccination?
por: Kahal, Deborah A, et al.
Publicado: (2021)

Inflammatory and Coagulation Biomarkers in Patients with Sars-COV2 Infection Receiving COVID-19 Convalescent Plasma: The Bergamo Registry
por: Marchetti, Marina, et al.
Publicado: (2022)

1213. Vaccine Uptake Amongst Participants in the North Carolina COVID-19 Community Research Partnership Who Were Initially Receptive or Hesitant to Receive a COVID-19 Vaccine
por: Munawar, Iqra, et al.
Publicado: (2021)

529. Systematic Review and Meta-Analysis of Ivermectin Safety Profile in COVID-19 Trials
por: Wentzel, Hannah, et al.
Publicado: (2021)

Meat consumption and risk of incident dementia: cohort study of 493,888 UK Biobank participants
por: Zhang, Huifeng, et al.
Publicado: (2021)

Piano quartets K. 478 & K. 493
por: Mozart, Wolfgang Amadeus, 1756-1791
Publicado: (1998)

905. Risk of Hepatitis B Reactivation in Patients Receiving Ibrutinib: The National VA Cohort
por: Chen, Ting-Yi, et al.
Publicado: (2021)

493 The Prevalence of Food Allergy in Children under 2 Years in Three Cities in China
por: Chen, Jing, et al.
Publicado: (2012)

521. Predictors of Hospitalization Due to Coronavirus Disease 2019 (COVID-19) at a Veterans Affairs Medical Center
por: Ho, Macy, et al.
Publicado: (2021)

Impact of Coronavirus (COVID-19) Pandemic on Maintenance Therapy for Follicular Lymphoma (FL) and Mantle Cell Lymphoma (MCL)
por: Serna, Angel, et al.
Publicado: (2022)

406. Incidence of Community and Hospital Acquired Infections in Critically Ill COVID-19 Patients in the Dominican Republic
por: Rojas-Fermin, Rita Alexandra, et al.
Publicado: (2021)

547. Risk Factors Associated with 30-Day Mortality in a Large Cohort of Patients who Received Remdesivir and Corticosteroids for Severe COVID-19
por: Gupta, Kartik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_doe8t3l3kh956e7d2dggdqe6ta